Alerts will be sent to your verified email
Verify Email
SENORES
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Senores Pharmaceuticals is global research driven pharmaceutical company engaged in developing and manufacturing a wide range of generic pharmaceutical products in the B2B segment predominantly for the Regulated Markets across various therapeutic areas and dosage forms.
Senores Pharmaceutic major competitors are Ajanta Pharma, Alembic Pharma, Caplin Point Lab, Gland Pharma, Strides Pharma Scien, Hikal, Vimta Labs.
Market Cap of Senores Pharmaceutic is ₹3,231 Crs.
While the median market cap of its peers are ₹16,028 Crs.
Senores Pharmaceutic seems to be less financially stable compared to its competitors.
Altman Z score of Senores Pharmaceutic is 5.74 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Jul | Dec | ||||||||||||||||
| Investor Presentation | May Jul | |||||||||||||||||
| Conference Call | Mar Jun | Dec | ||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
